Majority of women prefer non-invasive testing for trisomy 21

Majority of women prefer non-invasive testing for trisomy 21

(HealthDay)—The majority of both high-risk and intermediate-risk women prefer a non-invasive cell-free prenatal DNA screening (NIPT) as a secondary screening test for trisomy 21, according to a study published online Nov. 10 in BJOG: An International Journal of Obstetrics and Gynaecology.

Yvonne Kwun Yue Cheng, M.B.Ch.B., from The Chinese University of Hong Kong, and colleagues examined preference for follow-up testing in women who were screened as high or intermediate risk in first- or second-trimester Down syndrome . Testing options included either an invasive plus chromosomal microarray to obtain more detailed fetal genetic information or a NIPT to detect trisomies 13, 18, and 21 to avoid procedure-related miscarriage; the participants could also decline further testing.

The researchers found that of the 347 high-risk women, nearly all (99.1 percent) opted for follow-up testing, of whom 62.2 percent (216 women) chose NIPT. Of the 614 participants with intermediate risk, 82.6 percent (507 women) chose NIPT. Twenty-one percent of 34 women with nuchal translucency ≥3.5 mm opted for NIPT.

"In a setting where reporting times are similar and there is no cost difference between options, approximately 60 percent of high-risk would opt for NIPT offering simple but limited aneuploidy assessment over a diagnostic procedure with comprehensive and more detailed assessment," the authors write.

One author disclosed a royalty-producing patent related to non-invasive prenatal diagnostics.


Explore further

Invasive procedures down with noninvasive prenatal testing

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2017 HealthDay. All rights reserved.

Citation: Majority of women prefer non-invasive testing for trisomy 21 (2017, December 15) retrieved 26 January 2022 from https://medicalxpress.com/news/2017-12-majority-women-non-invasive-trisomy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors